$110.79+0.98%
2026-10-07 closeHalozyme Therapeutics's published financial data is dated 2026-10-04. 2024 revenue was $1.02B. 2024 operating profit was $551M.
Reported results
Quantus Signal · live data · not investment advice · Privacy Policy
Halozyme Therapeutics's published financial data is dated 2026-10-04. 2024 revenue was $1.02B. 2024 operating profit was $551M.